+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Fermented Ingredients - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • PDF Icon

    Report

  • 140 Pages
  • July 2026
  • Region: Global
  • Mordor Intelligence
  • ID: 5176257
The fermented ingredients market size was valued at USD 48.89 billion in 2025 and estimated to grow from USD 52.82 billion in 2026 to reach USD 77.72 billion by 2031, at a CAGR of 8.03% during the forecast period (2026-2031). This report is Segmented by Product Type (Amino Acids, Organic Acids, Polymers, Vitamins, Industrial Enzymes, and More), Form (Dry, and Liquid), Application (Food and Beverages, Animal Feed, Pharmaceutical, and More), and Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD) and Volume (Tons).

Global Fermented Ingredients Market Trends and Insights

Rising health and wellness awareness

Increasing health and wellness awareness is a key factor driving the growth of the fermented ingredients market. Consumers are increasingly seeking products that offer not only basic nutrition but also measurable health benefits. This trend has led to a significant rise in the adoption of fermented compounds, particularly probiotics and postbiotics, which are widely recognized for their benefits in supporting digestive health, immunity, and metabolic wellness. For example, Lactobacillus strains have been shown to reduce inflammatory markers in patients with metabolic syndrome, demonstrating their potential in managing chronic health conditions and improving overall well-being. The growing prevalence of lifestyle-related diseases further highlights the market potential. According to the International Diabetes Federation, approximately 11.1% of the global adult population had diabetes in 2024, with this figure projected to increase to 13% by 2050, underscoring the urgent need for preventive and functional nutrition solutions. Consequently, consumers are increasingly turning to functional foods, beverages, supplements, and nutraceuticals enriched with fermented ingredients.

Expansion of plant‑based diets

The growth of plant-based diets is significantly influencing the market, as consumers globally adopt vegetarian, vegan, and flexitarian eating habits driven by health, ethical, and environmental considerations. Fermented ingredients are playing a crucial role in improving the nutritional value, flavor, and digestibility of plant-based foods and beverages, which often lack certain essential nutrients present in animal-derived products. Fermentation enhances protein quality, increases the bioavailability of micronutrients, and improves functional properties. Additionally, it contributes to the development of natural flavors, textures, and shelf stability, making plant-based products more appealing and nutritionally balanced. This trend is particularly evident in categories such as dairy alternatives, plant-based meat substitutes, fermented beverages, and protein-enriched snacks, where fermented ingredients offer both technological and health-related advantages. The global rise in plant-based eating, coupled with concerns about sustainability and animal welfare, has driven significant demand for fermentation technologies that produce bioactive compounds, clean-label functional ingredients, and nutrient-rich formulations.

High production costs

High production costs pose a significant challenge for the fermented ingredients market, particularly in price-sensitive regions and applications. The production of fermented ingredients such as amino acids, probiotics, postbiotics, vitamins, and specialty enzymes involves complex microbial fermentation processes, rigorous quality control measures, and advanced downstream processing. These requirements demand substantial capital investment and operational expenses. Furthermore, ensuring consistent product quality, stability, and potency across batches often requires specialized equipment, controlled environments, and skilled personnel, further increasing costs. As a result, fermented ingredients are often more expensive than conventional synthetic alternatives or non-fermented options, which can limit their use in low-margin applications such as mass-market processed foods and basic animal feed.

Other drivers and restraints analyzed in the detailed report include:

  • Clean‑label and natural product trends
  • Technological advancements in fermentation
  • Regulatory challenges

Segment Analysis

The Amino Acids segment, accounting for 28.35% of the fermented ingredients market share in 2025, remains a significant contributor to the industry's growth. This is attributed to its broad applicability across various end-use sectors and its essential role in human and animal nutrition. Fermented amino acids, including lysine, glutamic acid, threonine, and tryptophan, are highly valued for their superior bioavailability and effectiveness compared to chemically synthesized alternatives. These attributes make them indispensable in food fortification, pharmaceuticals, and dietary supplements. Furthermore, increasing consumer awareness of protein-rich diets, sports nutrition, and the rising popularity of functional foods have significantly driven the demand for amino acids, particularly in developed markets.

The Probiotics and Postbiotics segment is the fastest-growing category in the fermented ingredients market, with a notable CAGR of 8.82% projected through 2031. This growth is primarily driven by increasing global awareness of gut health, immunity enhancement, and overall wellness. Rising consumer demand for natural and clean-label products has further supported the adoption of probiotics and postbiotics, as many consumers now favor preventive and holistic health approaches over synthetic alternatives. Additionally, the growing prevalence of gastrointestinal disorders worldwide has intensified this trend. For example, data from the National Institute of Statistics (ISTAT) indicates that approximately 1.15 million individuals of all ages in Italy were affected by peptic ulcer disease in 2023, underscoring a significant target population that could benefit from probiotic supplementation to improve digestive health and reduce complications.

Complete Report Scope:

  • By Product Type
    • Amino Acids
    • Organic Acids
    • Polymers
    • Vitamins
    • Industrial Enzymes
    • Antibiotics
    • Probiotics and Post-biotics
    • Others
  • By Form
    • Dry
    • Liquid
  • By Application
    • Food and Beverages
      • Dairy
      • Bakery and Confectionery
      • Beverages
      • Meat and Fish Products
      • Others
    • Animal Feed
    • Pharmaceutical
    • Personal Care and Cosmetics
    • Other Applications
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
      • Rest of North America
    • Europe
      • Germany
      • United Kingdom
      • Italy
      • France
      • Spain
      • Netherlands
      • Poland
      • Belgium
      • Sweden
      • Rest of Europe
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • Indonesia
      • South Korea
      • Thailand
      • Singapore
      • Rest of Asia-Pacific
    • South America
      • Brazil
      • Argentina
      • Colombia
      • Chile
      • Peru
      • Rest of South America
    • Middle East and Africa
      • South Africa
      • Saudi Arabia
      • United Arab Emirates
      • Nigeria
      • Egypt
      • Morocco
      • Turkey
      • Rest of Middle East and Africa

Geography Analysis

Asia-Pacific accounted for 34.20% of the fermented ingredients market share in 2025 and is projected to grow at a CAGR of 8.88% through 2031, making it the fastest-growing region globally. This growth is primarily driven by China's dominance in amino acid production and exports, which supports both domestic consumption and global supply chains. For example, data from the Observatory of Economic Complexity (OEC) indicates that China exported USD 1.5 billion worth of amino acids in 2024, highlighting its pivotal role in the global market. India is also emerging as a significant contributor, with its fermentation industry expanding rapidly due to government support, increased investment in biotechnology, and growing demand for functional foods, nutraceuticals, and animal feed. Factors such as a large population, rising health awareness, increasing disposable incomes, and expanding industrial capabilities position the Asia-Pacific as a key growth driver in the fermented ingredients market.

North America and Europe represent mature markets for fermented ingredients, characterized by slower volume growth but higher value generation. These regions benefit from trends such as premiumization, advanced Research and Development (R&D) capabilities, and regulatory-driven product reformulation. Manufacturers in these markets focus on developing clean-label, functional, and high-potency products to meet the growing consumer demand for health, wellness, and preventive nutrition. Europe, in particular, has seen strong adoption of probiotics, postbiotics, and organic acids in both food and pharmaceutical applications. Meanwhile, North America emphasizes innovation in functional beverages, nutraceuticals, and clinical nutrition products. The focus in these regions is on value creation, formulation advancements, and adherence to stringent regulatory standards, ensuring sustained profitability despite slower growth rates.

South America and the Middle East, and Africa present emerging opportunities for the fermented ingredients market, driven by increasing awareness of nutrition, food fortification initiatives, and the growth of functional food sectors. However, these regions face challenges such as infrastructure limitations, fragmented supply chains, and regulatory inconsistencies, which can hinder large-scale adoption. In South America, gradual adoption is observed in animal feed, dairy, and processed foods, while the Middle East and Africa show potential in functional foods, dairy products, and pharmaceuticals, particularly as urbanization and disposable incomes rise. Companies entering these markets must address logistical, regulatory, and educational challenges, but the untapped potential offers significant long-term growth opportunities as these regions continue to develop their food and health industries.


List of Companies Covered in this Report:

  • Ajinomoto Co. Inc.
  • Archer-Daniels-Midland Company
  • Associated British Foods PLC
  • BASF SE
  • Cargill, Incorporated
  • Chr. Hansen Holding A/S
  • Corbion NV
  • Dohler Group SE
  • DSM-Firmenich
  • DuPont (IFF Nutrition & Biosciences)
  • Evonik Industries AG
  • Kerry Group PLC
  • Kyowa Hakko Kirin Co. Ltd
  • Lallemand Inc.
  • Lesaffre
  • Lonza Group
  • Novonesis (Novozymes + Chr. Hansen enzymes)
  • Tate & Lyle PLC
  • Angel Yeast Co. Ltd
  • Meiji Holdings Co. Ltd

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY
4 MARKET LANDSCAPE
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising health and wellness awareness
4.2.2 Expansion of plant?based diets
4.2.3 Clean?label and natural product trends
4.2.4 Technological advancements in fermentation
4.2.5 Sustainability and eco?friendly production
4.2.6 Extended shelf life and natural preservation
4.3 Market Restraints
4.3.1 High production costs
4.3.2 Regulatory challenges
4.3.3 Supply chain vulnerabilities
4.3.4 Limited awareness in emerging markets
4.4 Supply Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces Analysis
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Buyers
4.7.3 Bargaining Power of Suppliers
4.7.4 Threat of Substitutes
4.7.5 Intensity of Competitive Rivalry
5 MARKET SIZE AND GROWTH FORECASTS (VALUE AND VOLUME)
5.1 By Product Type
5.1.1 Amino Acids
5.1.2 Organic Acids
5.1.3 Polymers
5.1.4 Vitamins
5.1.5 Industrial Enzymes
5.1.6 Antibiotics
5.1.7 Probiotics and Post-biotics
5.1.8 Others
5.2 By Form
5.2.1 Dry
5.2.2 Liquid
5.3 By Application
5.3.1 Food and Beverages
5.3.1.1 Dairy
5.3.1.2 Bakery and Confectionery
5.3.1.3 Beverages
5.3.1.4 Meat and Fish Products
5.3.1.5 Others
5.3.2 Animal Feed
5.3.3 Pharmaceutical
5.3.4 Personal Care and Cosmetics
5.3.5 Other Applications
5.4 By Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.1.4 Rest of North America
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 Italy
5.4.2.4 France
5.4.2.5 Spain
5.4.2.6 Netherlands
5.4.2.7 Poland
5.4.2.8 Belgium
5.4.2.9 Sweden
5.4.2.10 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 India
5.4.3.3 Japan
5.4.3.4 Australia
5.4.3.5 Indonesia
5.4.3.6 South Korea
5.4.3.7 Thailand
5.4.3.8 Singapore
5.4.3.9 Rest of Asia-Pacific
5.4.4 South America
5.4.4.1 Brazil
5.4.4.2 Argentina
5.4.4.3 Colombia
5.4.4.4 Chile
5.4.4.5 Peru
5.4.4.6 Rest of South America
5.4.5 Middle East and Africa
5.4.5.1 South Africa
5.4.5.2 Saudi Arabia
5.4.5.3 United Arab Emirates
5.4.5.4 Nigeria
5.4.5.5 Egypt
5.4.5.6 Morocco
5.4.5.7 Turkey
5.4.5.8 Rest of Middle East and Africa
6 COMPETITIVE LANDSCAPE
6.1 Market Concentration
6.2 Strategic Moves
6.3 Market Positioning Analysis
6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
6.4.1 Ajinomoto Co. Inc.
6.4.2 Archer-Daniels-Midland Company
6.4.3 Associated British Foods PLC
6.4.4 BASF SE
6.4.5 Cargill, Incorporated
6.4.6 Chr. Hansen Holding A/S
6.4.7 Corbion NV
6.4.8 Dohler Group SE
6.4.9 DSM-Firmenich
6.4.10 DuPont (IFF Nutrition & Biosciences)
6.4.11 Evonik Industries AG
6.4.12 Kerry Group PLC
6.4.13 Kyowa Hakko Kirin Co. Ltd
6.4.14 Lallemand Inc.
6.4.15 Lesaffre
6.4.16 Lonza Group
6.4.17 Novonesis (Novozymes + Chr. Hansen enzymes)
6.4.18 Tate & Lyle PLC
6.4.19 Angel Yeast Co. Ltd
6.4.20 Meiji Holdings Co. Ltd
7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Ajinomoto Co. Inc.
  • Archer-Daniels-Midland Company
  • Associated British Foods PLC
  • BASF SE
  • Cargill, Incorporated
  • Chr. Hansen Holding A/S
  • Corbion NV
  • Dohler Group SE
  • DSM-Firmenich
  • DuPont (IFF Nutrition & Biosciences)
  • Evonik Industries AG
  • Kerry Group PLC
  • Kyowa Hakko Kirin Co. Ltd
  • Lallemand Inc.
  • Lesaffre
  • Lonza Group
  • Novonesis (Novozymes + Chr. Hansen enzymes)
  • Tate & Lyle PLC
  • Angel Yeast Co. Ltd
  • Meiji Holdings Co. Ltd